Exciting times for cytomegalovirus (CMV) vaccine development: Navigating the pathways toward the goal of protecting infants against congenital CMV infection

Mark R. Schleiss, Don J. Diamond

Research output: Contribution to journal › Editorial › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Exciting times for cytomegalovirus (CMV) vaccine development: Navigating the pathways toward the goal of protecting infants against congenital CMV infection'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds